Corrigendum | Open Access
Corrigendum to “Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer”
In the article titled “Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1(PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer” , Drs. Jameel Muzaffar, Ahmad M. Haider, and Marjorie Adams Curry were missing from the authors’ list.
Dr. Jameel Muzaffar, MD, was responsible for manuscript guidance and preparation.
Dr. Ahmad M. Haider was responsible for statistical analysis and chart preparation.
Dr. Marjorie Adams Curry was responsible for providing partial list of patients who were treated with PDL1 inhibitors.
The corrected authors’ list is shown above, and it has been added in-line to the published article.
- S. Bari, J. Muzaffar, A. Chan et al., “Outcomes of programmed cell death protein 1 (PD-1) and programmed death-ligand 1(PD-L1) inhibitor therapy in HIV patients with advanced cancer,” Journal of Oncology, vol. 2019, Article ID 2989048, 5 pages, 2019.
Copyright © 2019 Shahla Bari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.